136 related articles for article (PubMed ID: 8981527)
1. Efficacy of recombinant human erythropoietin administered subcutaneously to CAPD patients once weekly.
Frifelt JJ; Tvedegaard E; Bruun K; Steffensen G; Cintin C; Breddam M; Dominguez H; Jørgensen JD
Perit Dial Int; 1996; 16(6):594-8. PubMed ID: 8981527
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal administration of recombinant human erythropoietin.
Frenken LA; Struijk DG; Coppens PJ; Tiggeler RG; Krediet RT; Koene RA
Perit Dial Int; 1992; 12(4):378-83. PubMed ID: 1420497
[TBL] [Abstract][Full Text] [Related]
3. Treatment of anaemia in dialysis patients with unit dosing of darbepoetin alfa at a reduced dose frequency relative to recombinant human erythropoietin (rHuEpo).
Locatelli F; Canaud B; Giacardy F; Martin-Malo A; Baker N; Wilson J
Nephrol Dial Transplant; 2003 Feb; 18(2):362-9. PubMed ID: 12543893
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
Pais MJ; Gaspar A; Santana A; Bruges M; Simões J
Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
[TBL] [Abstract][Full Text] [Related]
5. Comparison of intramuscular versus subcutaneous erythropoietin for the treatment of anemia in CAPD patients.
Abreo K; Lubom JA; Collier L; Fleming D; Work J
Adv Perit Dial; 1994; 10():124-8. PubMed ID: 7999809
[TBL] [Abstract][Full Text] [Related]
6. Once weekly versus twice weekly subcutaneous administration of recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Lui SF; Law CB; Ting SM; Li P; Lai KN
Clin Nephrol; 1991 Nov; 36(5):246-51. PubMed ID: 1752075
[TBL] [Abstract][Full Text] [Related]
7. Subcutaneous epoetin beta in renal anemia: an open multicenter dose titration study of patients on continuous peritoneal dialysis.
Bárány P; Clyne N; Hylander B; Johansson AC; Simonsen O; Larsson R; Frisenette-Fich C; Svensson B; Helmers C
Perit Dial Int; 1995; 15(1):54-60. PubMed ID: 7734561
[TBL] [Abstract][Full Text] [Related]
8. Once weekly subcutaneous administration of recombinant erythropoietin in children treated with CAPD.
Goldraich I; Goldraich N
Adv Perit Dial; 1992; 8():440-3. PubMed ID: 1361843
[TBL] [Abstract][Full Text] [Related]
9. Increase of the bioavailability of intraperitoneal erythropoietin in children on peritoneal dialysis by administration in small dialysis bags.
Reddingius RE; de Boer AW; Schröder CH; Willems JL; Monnens LA
Perit Dial Int; 1997; 17(5):467-70. PubMed ID: 9358528
[TBL] [Abstract][Full Text] [Related]
10. [Comparative study of the efficacy of different regimens of intermittent subcutaneous dosing of erythropoietin beta in treatment of renal anemia in chronic dialysis patients].
Nesić V; Ostrić V; Kovacević Z; Dimković N; Curić S; Lazarević M; Ratković M; Bogdanović J; Jelacić R
Med Pregl; 2005; 58(5-6):279-85. PubMed ID: 16526235
[TBL] [Abstract][Full Text] [Related]
11. Efficient monthly subcutaneous administration of darbepoetin in stable CAPD patients.
Theodoridis M; Passadakis P; Kriki P; Panagoutsos S; Yannatos E; Kantartzi K; Sivridis D; Vargemezis V
Perit Dial Int; 2005; 25(6):564-9. PubMed ID: 16411523
[TBL] [Abstract][Full Text] [Related]
12. Subcutaneous erythropoietin administration in predialysis patients: a single centre prospective study.
Branger B; Vécina F; Zabadani B; Balducchi JP; Fourcade J
Nephrol Dial Transplant; 1995; 10 Suppl 6():36-9. PubMed ID: 8524492
[TBL] [Abstract][Full Text] [Related]
13. Effects of subcutaneous recombinant human erythropoietin in patients on continuous ambulatory peritoneal dialysis.
Di Paolo B; Marini A; Fiederling B; Di Liberato L; Santarelli P; Bucciarelli S; Stuard S; Paolantonio L; Albertazzi A
Perit Dial Int; 1993; 13 Suppl 2():S538-40. PubMed ID: 8399659
[TBL] [Abstract][Full Text] [Related]
14. [The use of erythropoietin beta, two to three times per week, once per week and once every other week: meta-analysis of two clinical trials].
Pljesa S
Med Pregl; 2007; 60(3-4):123-7. PubMed ID: 17853722
[TBL] [Abstract][Full Text] [Related]
15. Effect of subcutaneous and intraperitoneal administration of recombinant human erythropoietin on blood pressure and vasoactive hormones in patients on continuous ambulatory peritoneal dialysis.
Lai KN; Lui SF; Leung JC; Law E; Nicholls MG
Nephron; 1991; 57(4):394-400. PubMed ID: 1828543
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of once-weekly epoetin alfa.
Barre P; Reichel H; Suranyi MG; Barth C
Clin Nephrol; 2004 Dec; 62(6):440-8. PubMed ID: 15630903
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of once weekly erythropoietin therapy in children on continuous ambulatory peritoneal dialysis.
Hisano S; Kaku Y; Ueda K; Onoyama K
Acta Paediatr Jpn; 1991 Aug; 33(4):450-4. PubMed ID: 1792903
[TBL] [Abstract][Full Text] [Related]
18. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
[TBL] [Abstract][Full Text] [Related]
19. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
Cody J; Daly C; Campbell M; Donaldson C; Khan I; Vale L; Wallace S; Macleod A
Cochrane Database Syst Rev; 2005 Jul; (3):CD003895. PubMed ID: 16034913
[TBL] [Abstract][Full Text] [Related]
20. A multicenter study with once a week or once every two weeks high-dose subcutaneous administration of recombinant human erythropoietin in continuous ambulatory peritoneal dialysis.
Nomoto Y; Kawaguchi Y; Kubota M; Tagawa H; Kubo K; Ogura Y; Shoji T; Kawada Y; Koshikawa S; Mimura N
Perit Dial Int; 1994; 14(1):56-60. PubMed ID: 8312416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
